U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334691) titled '"TARGET 2.0 Study": Safety and Performance of the Cardiovalve TR Replacement System' on Dec. 31, 2025.
Brief Summary: This investigation is a continuation for "TARGET" investigation and its purpose is to further demonstrate the efficiency and safety of the Cardiovalve system in the treatment of subjects with tricuspid regurgitation. The same subject population will be included, while applying the clinical and scientific knowledge accumulated in the TARGET investigation. This investigation will support the submission for obtaining marketing approval.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Tricuspid Reg...